UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Don’t Stop Post–Sustained Virologic Response Hepatocellular Carcinoma Surveillance Just Yet

Clinical infectious diseases, 2020-12, Vol.71 (9), p.2363-2364

2020

Volltextzugriff (PDF)

Hepatitis C: looking into the future

Expert review of gastroenterology & hepatology, 2020-05, Vol.14 (5), p.367-374

Massoud, Omar

2020

Volltextzugriff (PDF)

Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report

Journal of medical case reports, 2020-05, Vol.14 (1), p.62-62, Article 62

2020

Volltextzugriff (PDF)

Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019

Clinical infectious diseases, 2020-11, Vol.71 (16), p.2294-2297

2020

Volltextzugriff (PDF)

Two Cases of Hepatocellular Carcinoma Arising Over 20 years After a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C

Internal Medicine, 2020, pp.4479-20

2020

Volltextzugriff (PDF)

Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan

Internal Medicine, 2022, pp.0067-22

2022

Volltextzugriff (PDF)

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

Blood, 2017-04, Vol.129 (17), p.2437-2442

2017

Volltextzugriff (PDF)

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

Clinical infectious diseases, 2015-09, Vol.61 (5), p.730-740

2015

Volltextzugriff (PDF)

Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure?

Liver international, 2018-02, Vol.38 (S1), p.7-13

2018

Volltextzugriff (PDF)

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

The lancet HIV, 2019-04, Vol.6 (4), p.e259-e268

2019

Volltextzugriff (PDF)

Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study

American journal of transplantation, 2024-03, Vol.24 (3), p.468-478

2024

Volltextzugriff (PDF)

Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study

The Korean journal of internal medicine, 2022-11, Vol.37 (6), p.1167

2022

Volltextzugriff (PDF)

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy

Clinical infectious diseases, 2020-10, Vol.71 (7), p.e115-e124

2020

Volltextzugriff (PDF)

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2016-03, Vol.62 (6), p.683-694

2016

Volltextzugriff (PDF)

Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease

The Korean journal of internal medicine, 2022-09, Vol.37 (5), p.958

2022

Volltextzugriff (PDF)

Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?

Clinical infectious diseases, 2021-08, Vol.73 (3), p.468-477

2021

Volltextzugriff (PDF)

Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

The Journal of infectious diseases, 2016-12, Vol.214 (12), p.1965-1974

2016

Volltextzugriff (PDF)

Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2020-05, Vol.70 (11), p.2355-2365

2020

Volltextzugriff (PDF)

Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial

Annals of internal medicine, 2019-05, Vol.170 (9), p.594

2019

Volltextzugriff (PDF)

Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial

JAMA internal medicine, 2022-05, Vol.182 (5), p.494

2022

Volltextzugriff (PDF)

Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function

Liver international, 2016-06, Vol.36 (6), p.807-816

2016

Volltextzugriff (PDF)

Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis‐4 score and aspartate aminotransferase‐platelet ratio index

Liver international, 2017-03, Vol.37 (3), p.369-376

2017

Volltextzugriff (PDF)

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts

Liver international, 2020-08, Vol.40 (8), p.1841-1852

2020

Volltextzugriff (PDF)

Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy

Journal of viral hepatitis, 2016-12, Vol.23 (12), p.994-1002

2016

Volltextzugriff (PDF)

Non‐liver‐related mortality in the DAA era: Insights from post‐SVR patients with and without previous HCC history

Journal of medical virology, 2024-03, Vol.96 (3), p.e29432-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 1.258

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.111)
Mit Volltextzugriff
(1.124)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Sustained Virologic Response
(1.231)
Life Sciences & Biomedicine
(1.048)
Science & Technology
(1.048)
Humans
(1.002)
Male
(704)
Female
(682)
Antiviral Agents - Therapeutic Use
(670)
Middle Aged
(635)
Hepatitis C, Chronic - Drug Therapy
(626)
Hepatitis C
(590)
Gastroenterology & Hepatology
(553)
Adult
(490)
Treatment Outcome
(416)
Aged
(390)
Hepacivirus - Genetics
(369)
Hepatitis
(366)
Infectious Diseases
(345)
Hepatitis C Virus
(341)
Genotype
(339)
Drug Therapy, Combination
(312)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.003)
Journals@Ovid Full Text
(699)
EZB Electronic Journals Library
(604)
Wiley-Blackwell Journals
(462)
Wiley Online Library
(416)
Publisher or Other Site
(165)
Springer journals
(142)
Oxford Journals
(99)
Oxford Journals 2020 Medicine
(99)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(98)
JSTOR
(84)
IngentaConnect Journals
(60)
SAGE Journals
(51)
Taylor & Francis Journals
(49)
Taylor & Francis
(45)
Ebook Central Perpetual and DDA
(24)
Sociological Abstracts
(22)
eBooks on EBSCOhost
(20)
BMJ journals (British Medical Journal and others)
(16)
Taylor & Francis Online
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Don’t Stop Post–Sustained Virologic Response Hepatocellular Carcinoma Surveillance Just Yet

Hepatitis C: looking into the future

Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report

Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019

Two Cases of Hepatocellular Carcinoma Arising Over 20 years After a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C

Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure?

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study

Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease

Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?

Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis

Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial

Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial

Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function

Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis‐4 score and aspartate aminotransferase‐platelet ratio index

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts

Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy

Non‐liver‐related mortality in the DAA era: Insights from post‐SVR patients with and without previous HCC history

Aktive Filter

Suchergebnisse filtern